LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial

OBJECTIVES: This report from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial describes baseline lipase and amylase activity in type 2 diabetic subjects without acute pancreatitis symptoms before randomization to the glucagonlike peptide anal...

詳細記述

保存先:
書誌詳細
主要な著者: Steinberg, William M., Nauck, Michael A., Zinman, Bernard, Daniels, Gilbert H., Bergenstal, Richard M., Mann, Johannes F.E., Steen Ravn, Lasse, Moses, Alan C., Stockner, Mette, Baeres, Florian M.M., Marso, Steven P., Buse, John B.
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2014
主題:
Original Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4206347/
https://ncbi.nlm.nih.gov/pubmed/25275271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000229
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料